 | • レポートコード：MRC23Q36548 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の血管造影治療システム市場について調査・分析し、世界の血管造影治療システム市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（X線血管造影、CT血管造影、磁気共鳴血管造影、MR-CT血管造影）、用途別セグメント分析（循環器内科、腫瘍内科、神経内科、末梢血管インターベンション）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GE Healthcare、Koninklijke Philips N.V.、Siemens Healthineers、Canon Corporation、Boston Scientific Corporation、Cordis (a Cardinal Health Company, U.S.)、Shimadzu Corporation、Medtronic、Terumo、Braun Melsungen、Abbott Laboratoriesなどが含まれています。 世界の血管造影治療システム市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、血管造影治療システム市場規模を推定する際に考慮しました。本レポートは、血管造影治療システムの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、血管造影治療システムに関するビジネス上の意思決定に役立てることを目的としています。 ・血管造影治療システム市場の概要 - 製品の定義 - 血管造影治療システムのタイプ別セグメント - 世界の血管造影治療システム市場規模：タイプ別分析（X線血管造影、CT血管造影、磁気共鳴血管造影、MR-CT血管造影） - 血管造影治療システムの用途別セグメント - 世界の血管造影治療システム市場規模：用途別分析（循環器内科、腫瘍内科、神経内科、末梢血管インターベンション） - 世界の血管造影治療システム市場規模予測（2018年-2029年） - 血管造影治療システムの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 血管造影治療システム市場の競争状況およびトレンド ・血管造影治療システムの地域別市場規模 - 北米の血管造影治療システム市場規模（2018年-2029年） - アメリカの血管造影治療システム市場規模（2018年-2029年） - ヨーロッパの血管造影治療システム市場規模（2018年-2029年） - アジア太平洋の血管造影治療システム市場規模（2018年-2029年） - 中国の血管造影治療システム市場規模（2018年-2029年） - 日本の血管造影治療システム市場規模（2018年-2029年） - 韓国の血管造影治療システム市場規模（2018年-2029年） - インドの血管造影治療システム市場規模（2018年-2029年） - オーストラリアの血管造影治療システム市場規模（2018年-2029年） - 中南米の血管造影治療システム市場規模（2018年-2029年） - 中東・アフリカの血管造影治療システム市場規模（2018年-2029年） ・タイプ別セグメント：X線血管造影、CT血管造影、磁気共鳴血管造影、MR-CT血管造影 - 世界の血管造影治療システムのタイプ別販売量（2018年-2023年） - 世界の血管造影治療システムのタイプ別売上（2018年-2023年） - 世界の血管造影治療システムのタイプ別価格 ・用途別セグメント：循環器内科、腫瘍内科、神経内科、末梢血管インターベンション - 世界の血管造影治療システムの用途別販売量（2018年-2023年） - 世界の血管造影治療システムの用途別売上（2018年-2023年） - 世界の血管造影治療システムの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 GE Healthcare、Koninklijke Philips N.V.、Siemens Healthineers、Canon Corporation、Boston Scientific Corporation、Cordis (a Cardinal Health Company, U.S.)、Shimadzu Corporation、Medtronic、Terumo、Braun Melsungen、Abbott Laboratories ・産業チェーンと販売チャネルの分析 - 血管造影治療システム産業チェーン分析 - 血管造影治療システムの主要原材料 - 血管造影治療システムの販売チャネル - 血管造影治療システムのディストリビューター - 血管造影治療システムの主要顧客 ・血管造影治療システム市場ダイナミクス - 血管造影治療システムの業界動向 - 血管造影治療システム市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Angiographic Interventional Therapy System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Angiographic Interventional Therapy System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Angiographic Interventional Therapy System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Angiographic Interventional Therapy System include GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Corporation, Boston Scientific Corporation, Cordis (a Cardinal Health Company, U.S.), Shimadzu Corporation, Medtronic and Terumo, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Angiographic Interventional Therapy System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiographic Interventional Therapy System.
The Angiographic Interventional Therapy System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Angiographic Interventional Therapy System market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiographic Interventional Therapy System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GE Healthcare
Koninklijke Philips N.V.
Siemens Healthineers
Canon Corporation
Boston Scientific Corporation
Cordis (a Cardinal Health Company, U.S.)
Shimadzu Corporation
Medtronic
Terumo
Braun Melsungen
Abbott Laboratories
Segment by Type
X-ray Angiography
CT Angiography
Magnetic Resonance Angiography
MR-CT Angiography
Segment by Application
Cardiology
Oncology
Neurology
Peripheral Vascular Intervention
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiographic Interventional Therapy System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiographic Interventional Therapy System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Angiographic Interventional Therapy System Market Overview
1.1 Product Overview and Scope of Angiographic Interventional Therapy System
1.2 Angiographic Interventional Therapy System Segment by Type
1.2.1 Global Angiographic Interventional Therapy System Market Value Comparison by Type (2023-2029)
1.2.2 X-ray Angiography
1.2.3 CT Angiography
1.2.4 Magnetic Resonance Angiography
1.2.5 MR-CT Angiography
1.3 Angiographic Interventional Therapy System Segment by Application
1.3.1 Global Angiographic Interventional Therapy System Market Value by Application: (2023-2029)
1.3.2 Cardiology
1.3.3 Oncology
1.3.4 Neurology
1.3.5 Peripheral Vascular Intervention
1.4 Global Angiographic Interventional Therapy System Market Size Estimates and Forecasts
1.4.1 Global Angiographic Interventional Therapy System Revenue 2018-2029
1.4.2 Global Angiographic Interventional Therapy System Sales 2018-2029
1.4.3 Global Angiographic Interventional Therapy System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Angiographic Interventional Therapy System Market Competition by Manufacturers
2.1 Global Angiographic Interventional Therapy System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Angiographic Interventional Therapy System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Angiographic Interventional Therapy System Average Price by Manufacturers (2018-2023)
2.4 Global Angiographic Interventional Therapy System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Angiographic Interventional Therapy System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Angiographic Interventional Therapy System, Product Type & Application
2.7 Angiographic Interventional Therapy System Market Competitive Situation and Trends
2.7.1 Angiographic Interventional Therapy System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Angiographic Interventional Therapy System Players Market Share by Revenue
2.7.3 Global Angiographic Interventional Therapy System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Angiographic Interventional Therapy System Retrospective Market Scenario by Region
3.1 Global Angiographic Interventional Therapy System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Angiographic Interventional Therapy System Global Angiographic Interventional Therapy System Sales by Region: 2018-2029
3.2.1 Global Angiographic Interventional Therapy System Sales by Region: 2018-2023
3.2.2 Global Angiographic Interventional Therapy System Sales by Region: 2024-2029
3.3 Global Angiographic Interventional Therapy System Global Angiographic Interventional Therapy System Revenue by Region: 2018-2029
3.3.1 Global Angiographic Interventional Therapy System Revenue by Region: 2018-2023
3.3.2 Global Angiographic Interventional Therapy System Revenue by Region: 2024-2029
3.4 North America Angiographic Interventional Therapy System Market Facts & Figures by Country
3.4.1 North America Angiographic Interventional Therapy System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Angiographic Interventional Therapy System Sales by Country (2018-2029)
3.4.3 North America Angiographic Interventional Therapy System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Angiographic Interventional Therapy System Market Facts & Figures by Country
3.5.1 Europe Angiographic Interventional Therapy System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Angiographic Interventional Therapy System Sales by Country (2018-2029)
3.5.3 Europe Angiographic Interventional Therapy System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Angiographic Interventional Therapy System Market Facts & Figures by Country
3.6.1 Asia Pacific Angiographic Interventional Therapy System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Angiographic Interventional Therapy System Sales by Country (2018-2029)
3.6.3 Asia Pacific Angiographic Interventional Therapy System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Angiographic Interventional Therapy System Market Facts & Figures by Country
3.7.1 Latin America Angiographic Interventional Therapy System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Angiographic Interventional Therapy System Sales by Country (2018-2029)
3.7.3 Latin America Angiographic Interventional Therapy System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Angiographic Interventional Therapy System Market Facts & Figures by Country
3.8.1 Middle East and Africa Angiographic Interventional Therapy System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Angiographic Interventional Therapy System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Angiographic Interventional Therapy System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Angiographic Interventional Therapy System Sales by Type (2018-2029)
4.1.1 Global Angiographic Interventional Therapy System Sales by Type (2018-2023)
4.1.2 Global Angiographic Interventional Therapy System Sales by Type (2024-2029)
4.1.3 Global Angiographic Interventional Therapy System Sales Market Share by Type (2018-2029)
4.2 Global Angiographic Interventional Therapy System Revenue by Type (2018-2029)
4.2.1 Global Angiographic Interventional Therapy System Revenue by Type (2018-2023)
4.2.2 Global Angiographic Interventional Therapy System Revenue by Type (2024-2029)
4.2.3 Global Angiographic Interventional Therapy System Revenue Market Share by Type (2018-2029)
4.3 Global Angiographic Interventional Therapy System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Angiographic Interventional Therapy System Sales by Application (2018-2029)
5.1.1 Global Angiographic Interventional Therapy System Sales by Application (2018-2023)
5.1.2 Global Angiographic Interventional Therapy System Sales by Application (2024-2029)
5.1.3 Global Angiographic Interventional Therapy System Sales Market Share by Application (2018-2029)
5.2 Global Angiographic Interventional Therapy System Revenue by Application (2018-2029)
5.2.1 Global Angiographic Interventional Therapy System Revenue by Application (2018-2023)
5.2.2 Global Angiographic Interventional Therapy System Revenue by Application (2024-2029)
5.2.3 Global Angiographic Interventional Therapy System Revenue Market Share by Application (2018-2029)
5.3 Global Angiographic Interventional Therapy System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE Healthcare Angiographic Interventional Therapy System Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Koninklijke Philips N.V.
6.2.1 Koninklijke Philips N.V. Corporation Information
6.2.2 Koninklijke Philips N.V. Description and Business Overview
6.2.3 Koninklijke Philips N.V. Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Koninklijke Philips N.V. Angiographic Interventional Therapy System Product Portfolio
6.2.5 Koninklijke Philips N.V. Recent Developments/Updates
6.3 Siemens Healthineers
6.3.1 Siemens Healthineers Corporation Information
6.3.2 Siemens Healthineers Description and Business Overview
6.3.3 Siemens Healthineers Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Siemens Healthineers Angiographic Interventional Therapy System Product Portfolio
6.3.5 Siemens Healthineers Recent Developments/Updates
6.4 Canon Corporation
6.4.1 Canon Corporation Corporation Information
6.4.2 Canon Corporation Description and Business Overview
6.4.3 Canon Corporation Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Canon Corporation Angiographic Interventional Therapy System Product Portfolio
6.4.5 Canon Corporation Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Corporation Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boston Scientific Corporation Angiographic Interventional Therapy System Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 Cordis (a Cardinal Health Company, U.S.)
6.6.1 Cordis (a Cardinal Health Company, U.S.) Corporation Information
6.6.2 Cordis (a Cardinal Health Company, U.S.) Description and Business Overview
6.6.3 Cordis (a Cardinal Health Company, U.S.) Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Cordis (a Cardinal Health Company, U.S.) Angiographic Interventional Therapy System Product Portfolio
6.6.5 Cordis (a Cardinal Health Company, U.S.) Recent Developments/Updates
6.7 Shimadzu Corporation
6.6.1 Shimadzu Corporation Corporation Information
6.6.2 Shimadzu Corporation Description and Business Overview
6.6.3 Shimadzu Corporation Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shimadzu Corporation Angiographic Interventional Therapy System Product Portfolio
6.7.5 Shimadzu Corporation Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Corporation Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Medtronic Angiographic Interventional Therapy System Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
6.9 Terumo
6.9.1 Terumo Corporation Information
6.9.2 Terumo Description and Business Overview
6.9.3 Terumo Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Terumo Angiographic Interventional Therapy System Product Portfolio
6.9.5 Terumo Recent Developments/Updates
6.10 Braun Melsungen
6.10.1 Braun Melsungen Corporation Information
6.10.2 Braun Melsungen Description and Business Overview
6.10.3 Braun Melsungen Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Braun Melsungen Angiographic Interventional Therapy System Product Portfolio
6.10.5 Braun Melsungen Recent Developments/Updates
6.11 Abbott Laboratories
6.11.1 Abbott Laboratories Corporation Information
6.11.2 Abbott Laboratories Angiographic Interventional Therapy System Description and Business Overview
6.11.3 Abbott Laboratories Angiographic Interventional Therapy System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Abbott Laboratories Angiographic Interventional Therapy System Product Portfolio
6.11.5 Abbott Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Angiographic Interventional Therapy System Industry Chain Analysis
7.2 Angiographic Interventional Therapy System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Angiographic Interventional Therapy System Production Mode & Process
7.4 Angiographic Interventional Therapy System Sales and Marketing
7.4.1 Angiographic Interventional Therapy System Sales Channels
7.4.2 Angiographic Interventional Therapy System Distributors
7.5 Angiographic Interventional Therapy System Customers
8 Angiographic Interventional Therapy System Market Dynamics
8.1 Angiographic Interventional Therapy System Industry Trends
8.2 Angiographic Interventional Therapy System Market Drivers
8.3 Angiographic Interventional Therapy System Market Challenges
8.4 Angiographic Interventional Therapy System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer